Show simple item record

First Results of Intravenous Levetiracetam Use in Turkey

dc.contributor.authorBebek, Nerses
dc.contributor.authorKocasoy Orhan, Elif
dc.contributor.authorGurses, Candan
dc.date.accessioned2021-03-05T08:46:11Z
dc.date.available2021-03-05T08:46:11Z
dc.date.issued2012
dc.identifier.citationKocasoy Orhan E., Bebek N., Gurses C., "First Results of Intravenous Levetiracetam Use in Turkey", JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.29, ss.698-704, 2012
dc.identifier.issn1302-1664
dc.identifier.othervv_1032021
dc.identifier.otherav_9a90a7f1-2737-40c4-85c6-2a41afd0a4a6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/103907
dc.description.abstractObjective: Status epilepticus is a neurological emergency feature with a risk of high mortality and morbidity which requires immediate intervention. Many of the medications used in standard treatment have systemic side effects. Levetiracetam (LEV) is one of the new antiepileptic agents which are not metabolized through the liver and have minimal drug interaction. Positive outcomes with intravenous (IV) form of LEV on patients with refractory seizures and status have been reported.
dc.language.isoeng
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleFirst Results of Intravenous Levetiracetam Use in Turkey
dc.typeMakale
dc.relation.journalJOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume29
dc.identifier.issue4
dc.identifier.startpage698
dc.identifier.endpage704
dc.contributor.firstauthorID60629


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record